Research ArticleAdult Brain
Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma
E. George, E. Flagg, K. Chang, H.X. Bai, H.J. Aerts, M. Vallières, D.A. Reardon and R.Y. Huang
American Journal of Neuroradiology May 2022, 43 (5) 675-681; DOI: https://doi.org/10.3174/ajnr.A7488
E. George
aFrom the Department of Radiology and Biomedical Imaging (E.G.), University of California San Francisco, San Francisco, California
E. Flagg
bDepartment of Radiology (E.F., R.Y.H.), Brigham and Women’s Hospital, Boston, Massachusetts
K. Chang
cMassachusetts Institute of Technology (K.C.), Cambridge, Massachusetts
H.X. Bai
dDepartment of Diagnostic Imaging (H.X.B.), Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island
H.J. Aerts
eArtificial Intelligence in Medicine Program (H.J.A.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
fDepartments of Radiation Oncology and Radiology (H.J.A.), Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
M. Vallières
gDepartment of Computer Science (M.V.), Université de Sherbrooke, Sherbrooke, Quebec, Canada
D.A. Reardon
hCenter for Neuro Oncology (D.A.R.), Dana-Farber Cancer Institute, Boston, Massachusetts
R.Y. Huang
bDepartment of Radiology (E.F., R.Y.H.), Brigham and Women’s Hospital, Boston, Massachusetts
In this issue
American Journal of Neuroradiology
Vol. 43, Issue 5
1 May 2022
Advertisement
E. George, E. Flagg, K. Chang, H.X. Bai, H.J. Aerts, M. Vallières, D.A. Reardon, R.Y. Huang
Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma
American Journal of Neuroradiology May 2022, 43 (5) 675-681; DOI: 10.3174/ajnr.A7488
0 Responses
Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma
E. George, E. Flagg, K. Chang, H.X. Bai, H.J. Aerts, M. Vallières, D.A. Reardon, R.Y. Huang
American Journal of Neuroradiology May 2022, 43 (5) 675-681; DOI: 10.3174/ajnr.A7488
Related Articles
Cited By...
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- A. Prelaj, V. Miskovic, M. Zanitti, F. Trovo, C. Genova, G. Viscardi, S.E. Rebuzzi, L. Mazzeo, L. Provenzano, S. Kosta, M. Favali, A. Spagnoletti, L. Castelo-Branco, J. Dolezal, A.T. Pearson, G. Lo Russo, C. Proto, M. Ganzinelli, C. Giani, E. Ambrosini, S. Turajlic, L. Au, M. Koopman, S. Delaloge, J.N. Kather, F. de Braud, M.C. Garassino, G. Pentheroudakis, C. Spencer, A.L.G. PedrocchiAnnals of Oncology 2024 35 1
- Philipp Lohmann, Enrico Franceschi, Philipp Vollmuth, Frédéric Dhermain, Michael Weller, Matthias Preusser, Marion Smits, Norbert GalldiksThe Lancet Digital Health 2022 4 11
- Jiefeng Luo, Mika Pan, Ke Mo, Yingwei Mao, Donghua ZouSeminars in Cancer Biology 2023 91
- Anirban Das, Nicholas R. Fernandez, Adrian Levine, Vanessa Bianchi, Lucie K. Stengs, Jiil Chung, Logine Negm, Jose Rafael Dimayacyac, Yuan Chang, Liana Nobre, Ayse B. Ercan, Santiago Sanchez-Ramirez, Sumedha Sudhaman, Melissa Edwards, Valerie Larouche, David Samuel, An Van Damme, David Gass, David S. Ziegler, Stefan S. Bielack, Carl Koschmann, Shayna Zelcer, Michal Yalon-Oren, Gadi Abede Campino, Tomasz Sarosiek, Kim E. Nichols, Rebecca Loret De Mola, Kevin Bielamowicz, Magnus Sabel, Charlotta A. Frojd, Matthew D. Wood, Jason M. Glover, Yi-Yen Lee, Magimairajan Vanan, Jenny K. Adamski, Sebastien Perreault, Omar Chamdine, Magnus Aasved Hjort, Michal Zapotocky, Fernando Carceller, Erin Wright, Ivana Fedorakova, Alexander Lossos, Ryuma Tanaka, Michael Osborn, Deborah T. Blumenthal, Melyssa Aronson, Ute Bartels, Annie Huang, Vijay Ramaswamy, David Malkin, Adam Shlien, Anita Villani, Peter B. Dirks, Trevor J. Pugh, Gad Getz, Yosef E. Maruvka, Derek S. Tsang, Birgit Ertl-Wagner, Cynthia Hawkins, Eric Bouffet, Daniel A. Morgenstern, Uri TaboriCancer Discovery 2024 14 2
- Nastaran Khalili, Anahita Fathi Kazerooni, Ariana Familiar, Debanjan Haldar, Adam Kraya, Jessica Foster, Mateusz Koptyra, Phillip B. Storm, Adam C. Resnick, Ali Nabavizadehnpj Precision Oncology 2023 7 1
- Paniz Sabeghi, Paniz Zarand, Sina Zargham, Batis Golestany, Arya Shariat, Myles Chang, Evan Yang, Priya Rajagopalan, Daniel Phung, Ali GholamrezanezhadCancers 2024 16 3
- Di Chen, Rui Zhang, Xiaoming Huang, Chunxia Ji, Wei Xia, Ying Qi, Xinyu Yang, Lishuang Lin, Jing Wang, Haixia Cheng, Weijun Tang, Jinhua Yu, Dave S. B. Hoon, Jun Zhang, Xin Gao, Yu YaoBiomarker Research 2024 12 1
- Simone C. da Silva Rosa, Amir Barzegar Behrooz, Sofia Guedes, Rui Vitorino, Saeid GhavamiExpert Review of Proteomics 2024 21 4
- Ian Pan, Raymond Y. HuangCurrent Opinion in Neurology 2023 36 6
- Prajwal Ghimire, Ben Kinnersley, Golestan Karami, Prabhu Arumugam, Richard Houlston, Keyoumars Ashkan, Marc Modat, Thomas C BoothNeuro-Oncology Advances 2024 6 1
More in this TOC Section
Adult Brain
Similar Articles
Advertisement